• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

ACT:US

226.9800 USD 0.3900 0.17%

As of 20:04:04 ET on 08/29/2014.

Snapshot for Actavis plc (ACT)

Open: 227.0200 Day's Range: 225.5000 - 227.2300 Volume: 845,746
Previous Close: 226.5900 52wk Range: 134.7500 - 230.7700 1-Yr Rtn: +67.91%

Stock Chart for ACT

No chart data available.
  • ACT:US 226.9800
  • 1D
  • 1M
  • 1Y
226.5900
Interactive ACT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACT

Current P/E Ratio (ttm) 49.9321
Estimated P/E(12/2014) 17.1060
Relative P/E vs. SPX 2.7827
Earnings Per Share (USD) (ttm) 4.5458
Est. EPS (USD) (12/2014) 13.2690
Est. PEG Ratio 1.0912
Market Cap (M USD) 59,981.90
Shares Outstanding (M) 264.26
30 Day Average Volume 2,377,521
Price/Book (mrq) 4.0848
Price/Sale (ttm) 3.6729
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACT

Actavis plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Actavis offers its pharmaceutical drugs around the world.

Paul M BisaroChairmanBrenton L Saunders "Brent"President/CEO
R Todd JoyceChief Financial OfficerRobert A Stewart "Bob"Chief Operating Officer
More Company Profile & Key Executives for ACT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil